DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 2.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 35.6. According to RSI analysis, drreddy is weak. 3.0 DRREDDY RSI Chart
MACD (?) MACD: -32.6 and Signal Line: -20.3. According to MACD analysis, drreddy is technically weak. 2.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2994.87, 3028.564, 3127.203. 0.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2981.152, 3028.917, 3125.329. 0.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.144. According to bollinger bands, drreddy is technically weak. 3.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 2968.0232 and 3020.25. Support level is 2798.95. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 61.8 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 23.3 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 20, 2017
Open Price 2922.4
High Price 2925.05
Low Price 2890.0
Close Price 2898.75
Absolute Change -13.95
Percentage Change -0.479%
Weekly Change -2.3%
Monthly Change -1.65%
Yearly Change 1.8%
52-week high 3689.85
52-week low 2798.95
Corporate Actions
ExDate Purpose
July 18, 2016 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.487
Confidence in Beta1.14%
Market Capital Rs. 49446.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 36.6
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 February 2017: Deliverable Quantity:4.44e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 February 2017: Daily Volatility:0.2121 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 20 February 2017: PCR_OI:0.494 PCR:0.343 NA DRREDDY PCR Chart
Premium (?) 20 February 2017 Premium: 5.9 Futures OI:1973600.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 20 February 2017: Price:2898.75 Put with maximum OI:2800.0 Call with maximum OI:3100.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
February 23, 2017 2904.65 1973600.0 2840.0 3325.0 2898.75
March 30, 2017 2918.05 535800.0 1572.0 1938.0 2898.75
April 27, 2017 2953.95 600.0 2.0 2.0 2898.75

Option Chains - NSE

DRREDDY Option Zone

Announcements

February 16, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 16, 2017, titled "Dr. Reddy's announces US district court's opinion relating to patent infringement".
February 13, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 13, 2017, titled "Form 6-K for the quarter ended December 31, 2016, filed with United States Securities Exchange Commission".
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 05, 2016 October 25, 2016 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY 1.35
CNX100 1.14
CNX500 0.96
CNXPHARMA 18.7

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2849 Rs. 2870 Rs. 2884 Rs. 2905 Rs. 2919 Rs. 2940 Rs. 2954